CorVel (NASDAQ:CRVL) Announces Quarterly Earnings Results

by · The Cerbat Gem

CorVel (NASDAQ:CRVLGet Free Report) issued its quarterly earnings data on Tuesday. The business services provider reported $0.47 earnings per share (EPS) for the quarter, Zacks reports. CorVel had a return on equity of 31.72% and a net margin of 11.28%.

CorVel Trading Up 0.2%

CRVL opened at $69.75 on Tuesday. CorVel has a 12 month low of $65.47 and a 12 month high of $128.61. The business’s 50-day moving average price is $69.70 and its 200-day moving average price is $77.27. The company has a market cap of $3.57 billion, a P/E ratio of 34.36 and a beta of 1.06.

Wall Street Analysts Forecast Growth

CRVL has been the subject of several research analyst reports. Wall Street Zen lowered shares of CorVel from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CorVel in a report on Friday, January 9th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, CorVel presently has an average rating of “Hold”.

View Our Latest Stock Report on CRVL

Insider Buying and Selling

In related news, EVP Mark E. Bertels sold 1,200 shares of the company’s stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of $72.35, for a total transaction of $86,820.00. Following the completion of the sale, the executive vice president directly owned 2,594 shares in the company, valued at $187,675.90. This represents a 31.63% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director R Judd Jessup sold 7,076 shares of the company’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $76.94, for a total transaction of $544,427.44. Following the transaction, the director directly owned 115,045 shares of the company’s stock, valued at approximately $8,851,562.30. This trade represents a 5.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 11,733 shares of company stock valued at $894,686. Insiders own 44.56% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in CRVL. Northwestern Mutual Wealth Management Co. bought a new position in shares of CorVel during the third quarter valued at $31,000. Quarry LP grew its position in CorVel by 218.6% during the 3rd quarter. Quarry LP now owns 513 shares of the business services provider’s stock valued at $40,000 after purchasing an additional 352 shares during the last quarter. iSAM Funds UK Ltd bought a new stake in CorVel during the 3rd quarter valued at about $114,000. Caxton Associates LLP bought a new stake in CorVel during the 2nd quarter valued at about $262,000. Finally, State of Wyoming purchased a new position in CorVel in the second quarter worth about $297,000. Hedge funds and other institutional investors own 51.36% of the company’s stock.

About CorVel

(Get Free Report)

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).

Recommended Stories